XML 20 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Financial Instruments
3 Months Ended
Mar. 31, 2016
Financial Instruments Owned At Fair Value [Abstract]  
Financial Instruments

 

Note 3. Financial Instruments

Investments

The following tables present information about our cash equivalents and marketable securities measured at fair value on a recurring basis as of March 31, 2016 and December 31, 2015 based on the three-tier fair value hierarchy (in thousands):

 

 

 

Fair Value Measurement at

 

 

 

March 31, 2016

 

 

 

Level 1

 

 

Level 2

 

 

Total

 

Description

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

$

—

 

 

$

29,696

 

 

$

29,696

 

Money market funds

 

 

18,556

 

 

 

—

 

 

 

18,556

 

Asset-backed securities

 

 

—

 

 

 

10,025

 

 

 

10,025

 

U.S. treasury securities

 

 

—

 

 

 

9,211

 

 

 

9,211

 

Commercial paper

 

 

—

 

 

 

3,985

 

 

 

3,985

 

Agency securities

 

 

—

 

 

 

2,001

 

 

 

2,001

 

Total

 

$

18,556

 

 

$

54,918

 

 

$

73,474

 

Included in cash and cash equivalents

 

 

 

 

 

 

 

 

 

$

18,556

 

Included in marketable securities

 

 

 

 

 

 

 

 

 

$

54,918

 

 

 

 

 

Fair Value Measurement at

 

 

 

December 31, 2015

 

 

 

Level 1

 

 

Level 2

 

 

Total

 

Description

 

 

 

 

 

 

 

 

 

 

 

 

Corporate securities

 

$

—

 

 

$

31,761

 

 

$

31,761

 

Money market funds

 

 

21,338

 

 

 

—

 

 

 

21,338

 

Asset-backed securities

 

 

—

 

 

 

7,998

 

 

 

7,998

 

Commercial paper

 

 

—

 

 

 

5,992

 

 

 

5,992

 

U.S. treasury securities

 

 

—

 

 

 

4,001

 

 

 

4,001

 

Agency securities

 

 

—

 

 

 

1,998

 

 

 

1,998

 

Total

 

$

21,338

 

 

$

51,750

 

 

$

73,088

 

Included in cash and cash equivalents

 

 

 

 

 

 

 

 

 

$

21,338

 

Included in marketable securities

 

 

 

 

 

 

 

 

 

$

51,750

 

 

As of March 31, 2016 and December 31, 2015, there were no securities within Level 3 of the fair value hierarchy.  There were no transfers between fair value measurement levels during the three months ended March 31, 2016.  Gross unrealized gains or losses for cash equivalents and marketable securities as of March 31, 2016 and December 31, 2015 were not material. As of March 31, 2016 and December 31, 2015, there were no securities that were in an unrealized loss position for more than 12 months.

The following table classifies our marketable securities by contractual maturity as of March 31, 2016 and December 31, 2015 (in thousands):

 

 

 

March 31,

2016

 

 

December 31,

2015

 

Due in one year or less

 

$

36,531

 

 

$

29,414

 

Due after one year

 

 

18,387

 

 

 

22,336

 

Total

 

$

54,918

 

 

$

51,750

 

 

For certain other financial instruments, including accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their fair value due to the relatively short maturity of these balances.

Derivative Instruments and Hedging

Our foreign currency exposures typically arise from foreign operations and sales in foreign currencies for subscriptions to our customer service platform. In September 2015, we implemented a hedging program to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings. We enter into foreign currency forward contracts with certain financial institutions and designate those hedges as cash flow hedges. Our foreign currency forward contracts generally have maturities of 15 months or less but can extend up to 24 months. As of March 31, 2016, the balance of other accumulated comprehensive income included an unrealized gain of $1.9 million related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges. We expect to reclassify $1.1 million from accumulated other comprehensive income into earnings over the next 12 months associated with our cash flow hedges.

The following tables present information about derivative instruments on our consolidated balance sheets as of March 31, 2016 and December 31, 2015 (in thousands):

 

 

 

March 31, 2016

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

Derivative Instrument

 

Balance Sheet Location

 

Fair Value

(Level 2)

 

 

Balance Sheet Location

 

Fair Value

(Level 2)

 

Foreign currency forward contracts

 

Other current assets

 

 

1,867

 

 

Accrued liabilities

 

 

740

 

Foreign currency forward contracts

 

Other assets

 

 

719

 

 

Other

liabilities

 

 

6

 

Total

 

 

 

$

2,586

 

 

 

 

$

746

 

 

 

 

December 31, 2015

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

Derivative Instrument

 

Balance Sheet Location

 

Fair Value

(Level 2)

 

 

Balance Sheet Location

 

Fair Value

(Level 2)

 

Foreign currency forward contracts

 

Other current assets

 

 

408

 

 

Accrued liabilities

 

 

1,081

 

Total

 

 

 

$

408

 

 

 

 

$

1,081

 

 

Our foreign currency forward contracts had a total notional value of $99.9 million and $60.8 million as of March 31, 2016 and December 31, 2015, respectively. 

The following table presents information about our derivative instruments on the statement of operations for the three months ended March 31, 2016 (in thousands):

 

 

 

 

 

Three Months Ended March 31, 2016

 

Hedging Instrument

 

Location of Gain (Loss) Reclassified into Earnings

 

Gain Recognized in AOCI

 

 

Loss Reclassified from AOCI into Earnings

 

Foreign currency forward contracts

 

Revenue, cost of revenue, operating expenses

 

 

2,348

 

 

 

(262

)

Total

 

 

 

$

2,348

 

 

$

(262

)

 

There were no gains or losses on derivative instruments for the three months ended March 31, 2015.

All derivatives have been designated as hedging instruments. Amounts recognized in earnings related to excluded time value and hedge ineffectiveness were not material for the three months ended March 31, 2016.